89bio, Inc. Quarterly Marketable Securities, Current in USD from Q4 2022 to Q2 2024

Taxonomy & unit: us-gaap: USD
Description: Amount of investment in marketable security, classified as current.
Summary: 89bio, Inc. quarterly Marketable Securities, Current history and growth rate from Q4 2022 to Q2 2024.
89bio, Inc. Marketable Securities, Current for the quarter ending June 30, 2024 was $319M.

Marketable Securities, Current, Quarterly (USD)

Marketable Securities, Current, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q2 2024	$319M			Jun 30, 2024	10-Q	2024-08-05
Q1 2024	$345M			Mar 31, 2024	10-Q	2024-05-09
Q4 2023	$263M	+$130M	+97.7%	Dec 31, 2023	10-Q	2024-08-05
Q4 2022	$133M			Dec 31, 2022	10-K	2024-03-01

* An asterisk sign (*) next to the value indicates that the value is likely invalid.